Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The International Journal of Periodontics & Restorative Dentistry|March 14, 1998
Regenerative therapy in the treatment of maxillary molar Class II furcations: case reportsP S Rosen, M H Marks, G M Bowers
European Journal of Pharmacology|April 17, 1991
Effect of chronic ritanserin or clorgyline on amine and metabolite levels in rat frontal cortexE C Twist, S N Mitchell, T H Corn, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 1, 1988
Growth hormone response to clonidine after recovery in patients with endogenous depressionP B Mitchell, J A Bearn, T H Corn, et al.
The British Journal of Psychiatry : the Journal of Mental Science|June 1, 1984
A comparison of the growth hormone responses to clonidine and apomorphine in the same patients with endogenous depressionT H Corn, A S Hale, C Thompson, et al.
Biochemical Pharmacology|November 1, 1990
The effect of chronic ritanserin and clorgyline administration on 5-HT2 receptor linked inositol phospholipid hydrolysisE C Twist, M J Brammer, J D Stephenson, et al.
Ciba Foundation Symposium|January 1, 1986
Neuroendocrine and other studies of the mechanism of antidepressant action of desipramineS A Checkley, T H Corn, I B Glass, et al.
The British Journal of Psychiatry : the Journal of Mental Science|April 1, 1984
A neuroendocrine study of stereotactic sub-caudate tractotomyT H Corn, A Honig, C Thompson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 25, 2003
A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibitionA Clarke, F Brewer, E S Johnson, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 25, 2003
A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibitionA Clarke, E S Johnson, N Mallard, et al.
Biochemical and Biophysical Research Communications|April 9, 2009
Crystal structure of a catalytically active, non-toxic endopeptidase derivative of Clostridium botulinum toxin AGeoffrey Masuyer, Nethaji Thiyagarajan, Peter L James, et al.
Pageof 3